Yi Yao
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- Glycosylation and Glycoproteins Research
- RNA modifications and cancer
Papers in ⓘ
-
- RNA modifications and cancer 9
- Ubiquitin and proteasome pathways 9
- Oncology 40
- Cancer Immunotherapy and Biomarkers 14
- Co-authors
- Ching C. Wang (3 shared papers)E.I. Masters (2 shared papers)Christopher P. Hill (2 shared papers)Frank G. Whitby (2 shared papers)Qibin Song (26 shared papers)Wayne To (2 shared papers)Yong Yin (2 shared papers)Jeffrey L. Cleland (2 shared papers)
- Journals
- Frontiers in Oncology (8 papers)PLoS ONE (7 papers)Scientific Reports (4 papers)Thrombosis Research (3 papers)European Journal of Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesPakistan
In The Last Decade
Yi Yao
165 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 147
- Oncology 665
- Molecular Biology 1.6k
- Cell Biology 378
- Cancer Research 283
- Immunology 394
Countries citing papers authored by Yi Yao
This map shows the geographic impact of Yi Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Yao more than expected).
Fields of papers citing papers by Yi Yao
This network shows the impact of papers produced by Yi Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Yao. The network helps show where Yi Yao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Yao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 179 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 401 | |
| 2 | 2009 | 340 | |
| 3 | 2014 | 142 | |
| 4 | 2017 | 133 | |
| 5 | 2019 | 80 | |
| 6 | 2019 | 75 | |
| 7 | 2006 | 69 | |
| 8 | 2021 | 66 | |
| 9 | 2002 | 62 | |
| 10 | 2010 | 60 | |
| 11 | 2021 | 56 | |
| 12 | 1999 | 54 | |
| 13 | 2009 | 44 | |
| 14 | 2018 | 40 | |
| 15 | 2010 | 40 | |
| 16 | 2018 | 40 | |
| 17 | 1999 | 39 | |
| 18 | 2020 | 37 | |
| 19 | 2023 | 34 | |
| 20 | 2021 | 34 |
About Yi Yao
Yi Yao is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Cancer Research, having authored 179 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Ferroptosis and cancer prognosis (12 papers), Acute Myocardial Infarction Research (12 papers), Solid State Laser Technologies (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers), RNA modifications and cancer (9 papers), Ubiquitin and proteasome pathways (9 papers) and Photorefractive and Nonlinear Optics (8 papers). The work is most often cited by research in Oncology (665 citations), Molecular Biology (1.6k citations), Cell Biology (378 citations), Cancer Research (283 citations) and Immunology (394 citations). Yi Yao has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Ching C. Wang, E.I. Masters, Christopher P. Hill, Frank G. Whitby, Qibin Song, Wayne To, Yong Yin, Jeffrey L. Cleland, Michael D. Scholle and Volker Schellenberger. Their work appears in journals such as Frontiers in Oncology, PLoS ONE, Scientific Reports, Thrombosis Research and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.